---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-113096"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:19:48.986616+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Select Medical Q3 revenue up 5.7% to $1.76B; net income +33.2%; dividend $0.125; FY guidance updated

## Summary
- Q3 revenue $1,761.2M (+5.7% YoY); net income $81.0M (+33.2%); adjusted EPS $0.50 (+8.7%).
- Segment Adj. EBITDA: Critical Illness +9.5%, Rehab Hospital +12.1%, Concentra +2.7%.
- FY2024 guidance: revenue $6.95B–$7.15B; Adj. EBITDA $865M–$885M; adj. EPS $2.09–$2.20.
- Dividend $0.125/share declared, payable Nov 26 to holders of record Nov 13, 2024.
- No share repurchases in Q3; $600.3M total buybacks since program inception.

## SEC filing metadata
- accession: 0001104659-24-113096
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465924113096/0001104659-24-113096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465924113096/tm2427100d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-113096
- JSON: https://secwatch.observer/filing/0001104659-24-113096.json
- Plain text: https://secwatch.observer/filing/0001104659-24-113096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.